Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8+ T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8+ T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8+ T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8+ T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8+ T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Amino acids that bind to the B pocket of HLA-A alleles are broadly hydrophobic. By contrast, the B pocket of HLA-B alleles can accommodate a greater variety of residues (29, 39).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [29]
Citations
Cites
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,660
HLA and HIV-1: Heterozygote Advantage and B*35-Cw*04 Disadvantage
Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R., Buchbinder, S., Hoots, K., & O'Brien, S. J. (1999) · Science · doi:10.1126/science.283.5408.1748 · Cited by 1,224
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,189
Cooper, E. R., Charurat, M., Mofenson, L., Hanson, I. C., Pitt, J., Diaz, C., Hayani, K., Handelsman, E., Smeriglio, V., Hoff, R., et al. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204150-00009 · Cited by 1,058
Migueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D., Sullivan, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050567397 · Cited by 995
Kaslow, R. A., Carrington, M., Apple, R., Park, L., Muñoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0496-405 · Cited by 970
HIV evolution: CTL escape mutation and reversion after transmission
Leslie, A. J., Pfafferott, K. J., Chetty, P., Draenert, R., Addo, M. M., Feeney, M., Tang, Y., Holmes, E. C., Allen, T., Prado, J. G., et al. (2004) · Nature Medicine · doi:10.1038/nm992 · Cited by 847
Self-citationGarcia, P. M., Kalish, L. A., Pitt, J., Minkoff, H., Quinn, T. C., Burchett, S. K., Kornegay, J., Jackson, B., Moye, J., Hanson, C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410602 · Cited by 790
Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level
Moore, C. B., John, M., James, I. R., Christiansen, F. T., Witt, C. S., & Mallal, S. A. (2002) · Science · doi:10.1126/science.1069660 · Cited by 740
Self-citationAddo, M. M., Yu, X. G., Rathod, A., Cohen, D., Eldridge, R. L., Strick, D., Johnston, M. N., Corcoran, C., Wurcel, A. G., Fitzpatrick, C. A., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.2081-2092.2003 · Cited by 669
Self-citationPopulation Biology of Antigen Presentation by MHC Class I Molecules
Parham, P., & Ohta, T. (1996) · Science · doi:10.1126/science.272.5258.67 · Cited by 655
Cellular immune responses to HIV
McMichael, A. J., & Rowland-Jones, S. L. (2001) · Nature · doi:10.1038/35073658 · Cited by 616
HIV and SIV CTL escape: implications for vaccine design
Goulder, P. J. R., & Watkins, D. I. (2004) · Nature Reviews Immunology · doi:10.1038/nri1417 · Cited by 500
Self-citationEffect of a Single Amino Acid Change in MHC Class I Molecules on the Rate of Progression to AIDS
Gao, X., Nelson, G. W., Karacki, P., Martin, M. P., Phair, J., Kaslow, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442203 · Cited by 487
Genetics of susceptibitlity to human infectious disease
Cooke, G. S., & Hill, A. V. S. (2001) · Nature Reviews Genetics · doi:10.1038/35103577 · Cited by 444
Advantage of rare HLA supertype in HIV disease progression
Trachtenberg, E., Korber, B., Sollars, C., Kepler, T. B., Hraber, P. T., Hayes, E., Funkhouser, R., Fugate, M., Theiler, J., Hsu, Y. S., et al. (2003) · Nature Medicine · doi:10.1038/nm893 · Cited by 348
Self-citationUnusual HLA-B alleles in two tribes of Brazilian Indians
Belich, M. P., Madrigal, J. A., Hildebrand, W. H., Zemmour, J., Williams, R. C., Luz, R., Petzl-Erler, M. L., & Parham, P. (1992) · Nature · doi:10.1038/357326a0 · Cited by 282
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
Flores-Villanueva, P. O., Yunis, E. J., Delgado, J. C., Vittinghoff, E., Buchbinder, S., Leung, J. Y., Uglialoro, A. M., Clavijo, O. P., Rosenberg, E. S., Kalams, S. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071548198 · Cited by 263
Self-citationWatkins, D. I., McAdam, S. N., Liu, X., Strang, C. R., Milford, E. L., Levine, C. G., Garber, T. L., Dogon, A. L., Lord, C. I., Ghim, S. H., et al. (1992) · Nature · doi:10.1038/357329a0 · Cited by 248
HLA and AIDS: a cautionary tale
O'Brien, S. J., Gao, X., & Carrington, M. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02131-1 · Cited by 212
Molecular structure of human histocompatibility antigens: the HLA‐C series
Snary, D., Barnstable, C. J., Bodmer, W. F., & Crumpton, M. J. (1977) · European Journal of Immunology · doi:10.1002/eji.1830070816 · Cited by 181
Do infectious diseases drive MHC diversity?
Jeffery, K. J. M., & Bangham, C. R. M. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)01287-9 · Cited by 175
Comprehensive Analysis of Class I and Class II HLA Antigens and Chronic Hepatitis B Virus Infection
Thio, C. L., Thomas, D. L., Karacki, P., Gao, X., Marti, D., Kaslow, R. A., Goedert, J. J., Hilgartner, M. W., Strathdee, S. A., Duggal, P., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.22.12083-12087.2003 · Cited by 156
HLA‐B27 and the pathogenesis of spondyloarthritis
Ramos, M., & de Castro, J. A. L. (2002) · Tissue Antigens · doi:10.1034/j.1399-0039.2002.600301.x · Cited by 111
A uniquely high level of recombination at the HLA-B locus.
McAdam, S., Boyson, J. E., Liu, X., Garber, T. L., Hughes, A. L., Bontrop, R. E., & Watkins, D. I. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.5893 · Cited by 101
Initiating highly active antiretroviral therapy in sub-Saharan Africa
Badri, M., Bekker, L., Orrell, C., et al. (2004) · AIDS · doi:10.1097/00002030-200405210-00009 · Cited by 85
PCR-Sequence-Specific Primer Typing of HLA Class I and Class II Alleles
Bunce, M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-291-0:143 · Cited by 35
Self-citation
Research works printed but not linked: 1
- Marsh, S. G. E., Parham, P. & Barber, L. D. The HLA Facts Book (Academic, London, 2000)
Cited by
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Self-citationThe Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Study, T. I. H. C. (2010) · Science · doi:10.1126/science.1195271 · Cited by 1,171
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Chowell, D., Morris, L. G. T., Grigg, C. M., Weber, J. K., Samstein, R. M., Makarov, V., Kuo, F., Kendall, S. M., Requena, D., Riaz, N., et al. (2018) · Science · doi:10.1126/science.aao4572 · Cited by 1,142
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
Kiepiela, P., Ngumbela, K., Thobakgale, C., Ramduth, D., Honeyborne, I., Moodley, E., Reddy, S., de Pierres, C., Mncube, Z., Mkhwanazi, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1520 · Cited by 1,032
Self-citationDeeks, S. G., & Walker, B. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.010 · Cited by 759
Self-citation
Metadata
- Authors
- Kiepiela, P., Leslie, A. J., Honeyborne, I., Ramduth, D., Thobakgale, C., Chetty, S., Rathnavalu, P., Moore, C., Pfafferott, K. J., Hilton, L., Zimbwa, P., Moore, S., Allen, T., Brander, C., Addo, M. M., Altfeld, M., James, I., Mallal, S., Bunce, M., Barber, L. D., Szinger, J., Day, C., Klenerman, P., Mullins, J., Korber, B., Coovadia, H. M., Walker, B. D., & Goulder, P. J. R.
- Affiliations
- University of KwaZulu-Natal (ZA)
- University of Oxford (GB)
- Murdoch University (AU)
- University of Washington (US)
- Massachusetts General Hospital (US)
- Anthony Nolan (GB)
- Santa Fe Institute (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Goulder, Philip J. R.
- ORCID
- Venue
- Nature
- Published
- 2004-12
- Volume
- 432
- Issue
- 7018
- Pages
- 769-775
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2045551237
- Cited by
- 842
- References
- 27
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 11 · 2023: 16 · 2022: 21 · 2021: 25 · 2020: 19 · 2019: 29 · 2018: 30 · 2017: 30 · 2016: 25 · 2015: 38 · 2014: 38 · 2013: 49 · 2012: 69
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Murdoch University Research Portal (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- HLA-B, HLA-A, HIV-1, CD8+ T cell responses, HLA class I restriction, viral set point, CD4 count, disease progression, HLA polymorphism, HIV vaccine design
- MeSH terms
- Africa, Southern, Biological Evolution, Female, Gene Frequency, Humans, Infant, Male, Polymorphism, Genetic, HLA-A Antigens, HLA-B Antigens, HIV-1, HIV Infections, Gene Products, nef, CD8-Positive T-Lymphocytes, Epitopes, T-Lymphocyte, Viral Load, nef Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.